美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA213425"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
71839-108-01 71839-108 HUMAN PRESCRIPTION DRUG daptomycin daptomycin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20200820 N/A ANDA ANDA213425 BE Pharmaceuticals Inc. DAPTOMYCIN 350 mg/7mL 1 VIAL in 1 CARTON (71839-108-01) / 7 mL in 1 VIAL
71839-108-10 71839-108 HUMAN PRESCRIPTION DRUG daptomycin daptomycin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20200820 N/A ANDA ANDA213425 BE Pharmaceuticals Inc. DAPTOMYCIN 350 mg/7mL 10 VIAL in 1 CARTON (71839-108-10) / 7 mL in 1 VIAL
69097-850-67 69097-850 HUMAN PRESCRIPTION DRUG daptomycin daptomycin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION INTRAVENOUS 20210326 N/A ANDA ANDA213425 Cipla USA Inc. DAPTOMYCIN 350 mg/7mL 1 VIAL in 1 CARTON (69097-850-67) / 7 mL in 1 VIAL
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase